[Modeling Parkinson's disease and objectifying the nigro-striatum system dysfunction].
作者信息
Chekhonin V P, Baklaushev V P, Dmitrieva T B
出版信息
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(1):59-68.
PMID:14870697
Abstract
摘要
相似文献
1
[Modeling Parkinson's disease and objectifying the nigro-striatum system dysfunction].[帕金森病建模与黑质纹状体系统功能障碍的客观化]
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(1):59-68.
2
Modifications of neuroactive steroid levels in an experimental model of nigrostriatal degeneration: potential relevance to the pathophysiology of Parkinson's disease.神经活性甾体水平在黑质纹状体变性实验模型中的改变：与帕金森病病理生理学的潜在相关性。
J Mol Neurosci. 2012 Jan;46(1):177-83. doi: 10.1007/s12031-011-9570-y. Epub 2011 Jun 14.
3
Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression.黑质纹状体多巴胺通路单侧损伤对大鼠束旁核神经元存活及神经化学的影响——时间进程和LGR8表达评估
Brain Res. 2009 May 19;1271:83-94. doi: 10.1016/j.brainres.2009.03.026. Epub 2009 Mar 25.
4
CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.CGP 56999A，一种γ-氨基丁酸（B）受体拮抗剂，在黑质纹状体通路经6-羟基多巴胺损伤后，可增强大鼠纹状体内脑源性神经营养因子的表达并减轻多巴胺耗竭。
Neurosci Lett. 2006 Oct 2;406(1-2):102-6. doi: 10.1016/j.neulet.2006.07.004. Epub 2006 Aug 4.
5
Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.部分多巴胺缺失增强活化的半胱天冬酶-3活性：纹状体投射系统中的不同结果。
J Neurosci Res. 2005 Nov 1;82(3):387-96. doi: 10.1002/jnr.20644.
6
Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.在帕金森病大鼠运动皮层激活期间，纹状体功能障碍会增加基底神经节输出。
Eur J Neurosci. 2007 May;25(9):2791-804. doi: 10.1111/j.1460-9568.2007.05527.x.
7
Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.6-羟多巴胺诱导的大鼠帕金森病轴突和末端病变模型中黑质纹状体神经退行性变和神经炎症的时程。
Neuroscience. 2011 Feb 23;175:251-61. doi: 10.1016/j.neuroscience.2010.12.005. Epub 2010 Dec 9.
8
Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation.外源性左旋多巴不会在患有广泛黑质纹状体多巴胺能去神经支配的成年大鼠的纹状体星形胶质细胞和小胶质细胞中诱导多巴胺免疫反应性。
Neurosci Lett. 2008 Mar 15;433(3):255-8. doi: 10.1016/j.neulet.2008.01.030. Epub 2008 Jan 18.
9
Animal models of Parkinson's disease.帕金森病的动物模型。
Bioessays. 2002 Apr;24(4):308-18. doi: 10.1002/bies.10067.
10
Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDA-induced rat model of Parkinson disease.在6-羟基多巴胺诱导的帕金森病大鼠模型中，FasL的表达及其与Fas的相互作用由c-Jun氨基末端激酶（JNK）途径介导。
Neurosci Lett. 2007 Nov 27;428(2-3):82-7. doi: 10.1016/j.neulet.2007.09.032. Epub 2007 Sep 25.
Zotero 插件